Keywords
Utkatar, pre-diabetic, Echinops echinatus, Utkatar root ghana
This article is included in the Datta Meghe Institute of Higher Education and Research collection.
In Ayurveda, disease causing biophysical energies (dosha) should be conquered at the initial stage. In the six stages of disease formation (Shatkriyakal), symptoms and signs can be seen in the localization stage (Sthansamshray), where amalgamation of vitiated biophysical energies with weak and susceptible tissues (dosha–dushya sammurchana) occur thereby manifesting disease. Echinops echinatus Roxb (Utkatar) is a traditionally used, classically described extra-pharmacopeial drug in Ayurveda, but less scientifically (clinically) explored medicinal herb. Few pre-clinical studies done on this plant revealed its anti-diabetic action but no clinical trial is noted till date. So, there is an urgent need to bridge the gap between the pre-clinical studies and empirical knowledge. Hence the present research work will be undertaken with the aim of exploring the anti-diabetic potential of Echinops echinatus Roxb (Utkatar) in Type II pre-diabetic patients.
Comparative evaluation of the anti-diabetic activity of Echinops echinatus Roxb (Utkatara) root ghana versus Nishaamalaki in pre-diabetic patients.
A total of 60 participants who meet the inclusion criteria will be chosen after conducting a drug analysis and divided into two groups of 30 each. Both Echinops echinatus Roxb (Utkatar) root ghana and Nishaamalaki will be administered twice daily for 30 days to groups A and B, respectively. After the intervention, assessment will be conducted on days 0, 1, 15, and 30. Day 45 will be reserved for follow-up.
The observations of objective characteristics will be used to derive the results.
Based on statistical information derived from the data gathered, the study’s conclusion will be made.
Utkatar, pre-diabetic, Echinops echinatus, Utkatar root ghana
A chronic disease, diabetes mellitus (DM) is distinguished by high blood sugar levels brought on by a lack of insulin (Type I DM) and relative insulin deficiency with or without insulin resistance (Type II DM).1 Diabetes prevalence varies greatly between urban and rural populations, with rural areas having a 2.5% prevalence and urban areas having a 14.6% prevalence.1 According to the Ministry of Health, 74.2 million people in India’s 20- to 79-year-old age group are anticipated to have diabetes as of December 2021. Sedentary lifestyles are the main contributor to the rise in diabetic patients around the world, which is anticipated to reach 366 million in the older population (those over 65).2
It is linked to a severe dysregulation of lipid, protein, and glucose metabolism that gradually gives rise to life-threatening consequences.3 Chronic hyperglycaemia is a characteristic shared by all the diverse disorders grouped under diabetes mellitus.4 Advanced glycation end products (AGEs) are circulating at higher levels as a result of long-term hyperglycaemia, which increases the risk of stroke and myocardial infarction as well as vascular problems that can result in diabetic retinopathy, neuropathy, and nephropathy.5 Maintaining a stable blood glucose level is essential for delaying vascular problems and preventing the formation of AGEs.6 The existing anti-diabetic medicine has a substantial number of side effects, thus there is still a need to look for medicinal herbs with useful anti-hyperglycaemic properties.6 In Ayurveda, diabetes mellitus can be co-related with Prameha and has been successfully treated from ancient time.7,8
In Gujarat, diabetes is treated by using the Echinops echinatus root bark suspension with milk.9 In Kerala, however, the whole plant is infused with a decoction to cure diabetes, along with leaf paste and leaf powder.10
Echinops echinatus Roxb. (Utkatar) is a traditionally used, classically described extra-pharmacopeial drug in Ayurveda. But less scientifically (clinically) explored medicinal herb. Few pre-clinical studies done on this plant revealed its anti-diabetic action but no clinical trial is found till date. So, there is an urgent need to bridge the gap between the pre-clinical studies and empirical knowledge. Hence the present research work is undertaken with the aim of exploring the anti-diabetic potential of Echinops echinatus Roxb (Utkatar) in Type II pre-diabetic patients.
Aim: The aim of this study is to compare and evaluate the anti-diabetic activity of Echinops echinatus Roxb (Utkatar) root ghana versus Nishaamalaki in pre-diabetic patients.
The study will be started after the clearance from the I.E.C. of Mahatma Gandhi Ayurved College, Hospital and Research Centre, Salod(H), Wardha (I.E.C. REF No.: MGACHRC/IEC/July-2022/544 which was done on 11/08/2022) and after CTRI registration (CTRI/2023/11/059445).
The endpoint and oversee of trial will be done by the committee.
The researcher will assess any adverse event and will be reported to the committee.
The written informed consent will be taken from the patient before starting the study.
During the study, the confidentiality of each patient will be maintained.
It will be a single-blind parallel randomized control experiment. Study intervention will be done using a 1:1 ratio on two groups.
Patients will be recruited from the Kayachikitsa and Panchakarma Out-patient Department (OPD) and In-patient Department (IPD) of Mahatma Gandhi Ayurveda College, Hospital and Research Centre, Wardha and from peripheral medical camps.
A total of 60 patients will be selected for the study. Randomization will be done and the patients will be divided into two groups; for group A- Echinops echinatus Roxb (Utkatar) root ghana and group B- Nishaamalaki will be given. All the baseline parameters will be recorded at the start of the study. The patients will undergo treatment for 30 days and follow-up will be done on days 0, 1, 15, 30, and 45.
The SPIRIT guidelines were considered for the study protocol,16 while the CONSORT guidelines will be considered for the study.
Patients with pre-diabetes who have fasting blood sugar levels greater than 126 mg/dL and post-meal blood sugar levels greater than 200 mg/dL will be chosen for the trial.
Simple randomization will be done.
The researcher will generate the allocation sequence, enrol the participants, and assign participants to the intervention.
Mature roots of E. echinatus will be collected from the campus of Mahatma Gandhi Ayurved College, Hospital and Research Centre, Salod (H), Wardha. It will be washed to remove foreign matter and shade dried. Then, it will be cut into pieces and made into a coarse powder (bharad) with the help of a grinder at Dattatray Ayurved Rasashala of Mahatma Gandhi Ayurvedic College Hospital and Research Centre, Salod(H), Wardha (GMP certificate Ayurved pharmacy Licence No.NG/AYU/002/14). For decoction, 1:16 proportion of drug and water i.e., 1 part of Utkatara powder and 16 parts of water will be taken and boiled reduce it to 1/8th.11 The decoction (quath) will be taken in a vessel and heating process will be carried out on the gas stove with continuously stirring it unless it will get converted into semisolid form. Thus, ghana will be prepared from decoction (quath) and proceed for characterization12,13 as shown in Figure 2.
Patients will be removed from the study if they experience any events, drug susceptibility characteristics, or other illnesses or conditions. The patients will receive free treatment until their condition improves.
To assess and compare the efficacy of Echinops echinatus Roxb (Utkatar) root ghana versus Nishaamalaki in pre-diabetic condition.
It consists of the following steps as shown in Table 1.
The study will be conducted in Mahatma Gandhi Ayurved College Hospital and Research Centre Salod (H) Wardha and from specialized peripheral camps. A total of 60 patients will be recruited for the study.
A simple random sampling technique using a computerized table method will be used for the study.
The principal investigator will register an allocation sequence, enrol the participants and assign the intervention.
It is a single blind superiority clinical trial i.e., a clinical trial in which the experimenters are aware of which subjects are receiving the treatment or independent variable, but the participants of the study are not.
Intervention will be given as mentioned in Table 2.
Mature roots of Echinops echinatus Roxb (Utkatar) will be collected from the field in appropriate season as per WHO Good Collection Practices (GCP) guidelines14 and classical Ayurvedic text (Charak Samhita).15 The plant sample will be collected from its natural habitat and will be authenticated by sending a specimen voucher to the Foundation for Revitalization of Local Health Traditions (FRLHT), Bangalore pharmacognosy lab.
Since Echinops echinatus Roxb (Utkatar) is a folklore medicinal plant, The aim of this research is to provide simple, safe, and affordable methods for managing diabetes. The study also seeks to develop effective remedies for the condition. If the results of this research are positive, it will set a benchmark for future studies and establish the best treatment method for diabetes mellitus.
Minal S. Tadke and Rajkumar Gupta did the conceptualization and study design. Minal S. Tadke will do this clinical trial. The discussion and data analysis were done by Swapna Bokhad, Swanand Joshi, and Dattatray Sarvade. For the final manuscript, the methodology and results were discussed by all the authors.
No data are associated with this article.
Zenodo: SPIRIT checklist for ‘Comparative evaluation of the anti-diabetic activity of Echinops echinatus Roxb (Utkatar) root ghana versus Nishaamalaki in pre-diabetic patients – a study protocol’. https://doi.org/10.5281/zenodo.8170571. 16
Data are available under the terms of the Creative Commons Attribution 4.0 International license (CC-BY 4.0).
The authors would like to express their gratitude to the authors, editors, and publishers of all the papers, journals, and books that were reviewed and debated to complete this work. Additionally, the authors would like to thank the anonymous peer reviewers from Books & Texts for their insightful comments.
Views | Downloads | |
---|---|---|
F1000Research | - | - |
PubMed Central
Data from PMC are received and updated monthly.
|
- | - |
Is the rationale for, and objectives of, the study clearly described?
Yes
Is the study design appropriate for the research question?
Yes
Are sufficient details of the methods provided to allow replication by others?
Yes
Are the datasets clearly presented in a useable and accessible format?
Partly
Competing Interests: No competing interests were disclosed.
Reviewer Expertise: Area of Research: Exporation of Ayurveda concepts through Quantum Physics and researches on Ayurveda Medicinal Plants
Alongside their report, reviewers assign a status to the article:
Invited Reviewers | |
---|---|
1 | |
Version 1 27 Nov 23 |
read |
Provide sufficient details of any financial or non-financial competing interests to enable users to assess whether your comments might lead a reasonable person to question your impartiality. Consider the following examples, but note that this is not an exhaustive list:
Sign up for content alerts and receive a weekly or monthly email with all newly published articles
Already registered? Sign in
The email address should be the one you originally registered with F1000.
You registered with F1000 via Google, so we cannot reset your password.
To sign in, please click here.
If you still need help with your Google account password, please click here.
You registered with F1000 via Facebook, so we cannot reset your password.
To sign in, please click here.
If you still need help with your Facebook account password, please click here.
If your email address is registered with us, we will email you instructions to reset your password.
If you think you should have received this email but it has not arrived, please check your spam filters and/or contact for further assistance.
Comments on this article Comments (0)